首页 > 最新文献

Texas Heart Institute Journal最新文献

英文 中文
Use of Ultrasound-Assisted, Catheter-Directed Thrombolysis in a Patient With High-Risk Pulmonary Embolism. 在高危肺栓塞患者中使用超声辅助导管引导溶栓疗法
IF 0.9 4区 医学 Pub Date : 2024-02-06 DOI: 10.14503/THIJ-23-8235
Karam P S Gill, Daniel P O'Brien, Jonathan E Soverow

High-risk pulmonary embolism (PE) is a complex clinical entity associated with high mortality rates. Ultrasound-assisted, catheter-directed thrombolysis, typically used for intermediate-risk PE, may be a viable treatment approach for high-risk PE, particularly in patients at increased risk for major bleeding. This report describes a case in which ultrasound-assisted, catheter-directed thrombolysis was successfully used to treat high-risk PE in a female patient with extensive peritoneal metastases from gastric adenocarcinoma. Other examples from the literature, in which ultrasound-assisted, catheter-directed thrombolysis was used to treat high-risk PE, are also provided.

高危肺栓塞(PE)是一种与高死亡率相关的复杂临床实体。超声辅助导管引导溶栓通常用于中危肺栓塞,而对于高危肺栓塞,尤其是大出血风险较高的患者,超声辅助导管引导溶栓可能是一种可行的治疗方法。本报告描述了一例成功使用超声辅助导管引导溶栓治疗高危 PE 的病例,患者为女性,胃腺癌广泛腹膜转移。此外,还提供了文献中利用超声辅助导管引导溶栓治疗高危 PE 的其他实例。
{"title":"Use of Ultrasound-Assisted, Catheter-Directed Thrombolysis in a Patient With High-Risk Pulmonary Embolism.","authors":"Karam P S Gill, Daniel P O'Brien, Jonathan E Soverow","doi":"10.14503/THIJ-23-8235","DOIUrl":"10.14503/THIJ-23-8235","url":null,"abstract":"<p><p>High-risk pulmonary embolism (PE) is a complex clinical entity associated with high mortality rates. Ultrasound-assisted, catheter-directed thrombolysis, typically used for intermediate-risk PE, may be a viable treatment approach for high-risk PE, particularly in patients at increased risk for major bleeding. This report describes a case in which ultrasound-assisted, catheter-directed thrombolysis was successfully used to treat high-risk PE in a female patient with extensive peritoneal metastases from gastric adenocarcinoma. Other examples from the literature, in which ultrasound-assisted, catheter-directed thrombolysis was used to treat high-risk PE, are also provided.</p>","PeriodicalId":48680,"journal":{"name":"Texas Heart Institute Journal","volume":"51 1","pages":""},"PeriodicalIF":0.9,"publicationDate":"2024-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11075505/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139693317","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of Perioperative and Postoperative Outcomes Among 3 Left Atrial Incisions: Conventional Direct, Transseptal, and Superior Septal Left Atriotomy. 三种左心房切口围手术期和术后结果的比较:传统直接切口、经隔切口和上隔左心房切开术
IF 0.9 4区 医学 Pub Date : 2024-01-31 DOI: 10.14503/THIJ-23-8162
Estelle Démoulin, Dionysios Adamopoulos, Tornike Sologashvili, Mathieu van Steenberghe, Jalal Jolou, Haran Burri, Christoph Huber, Mustafa Cikirikcioglu

Background: Achieving optimal exposure of the mitral valve during surgical intervention poses a significant challenge. This study aimed to compare perioperative and postoperative outcomes associated with 3 left atriotomy techniques in mitral valve surgery-the conventional direct, transseptal, and superior septal approaches-and assess differences during the surgical procedure and the postoperative period.

Methods: Inclusion criteria were patients undergoing mitral valve surgery from January 2010 to December 2020, categorized into 3 cohorts: group 1 (conventional direct; n = 115), group 2 (transseptal; n = 33), and group 3 (superior septal; n = 59). To bolster sample size, the study included patients undergoing mitral valve surgery independently or in conjunction with other procedures (eg, coronary artery bypass grafting, aortictricuspid surgery, or maze procedure).

Results: No substantial variance was observed in the etiology of mitral valve disease across groups, except for a higher incidence of endocarditis in group 3 (P = .01). Group 1 exhibited a higher frequency of elective surgeries and isolated mitral valve procedures (P = .008), along with reduced aortic clamping and cardiopulmonary bypass durations (P = .002). Conversely, group 3 patients represented a greater proportion of emergency procedures (P = .01) and prolonged intensive care unit and hospital stays (P = .001). No significant disparities were detected in terms of permanent pacemaker implantation, postoperative complications, or mortality among the groups.

Conclusion: Mitral valve operations that employed these 3 atriotomy techniques demonstrated a safe profile. The conventional direct approach notably reduced aortic clamping and cardiopulmonary bypass durations. The superior septal method was primarily employed for acute pathologies, with no significant escalation in postoperative arrhythmias or permanent pacemaker implantation, although these patients had prolonged intensive care unit and hospital stays. These outcomes may be linked to the underlying pathology and nature of the surgical intervention rather than the incision method itself.

背景:在手术干预中实现二尖瓣的最佳暴露是一项重大挑战。本研究旨在比较二尖瓣手术中 3 种左心房切开术(传统直接入路、经隔入路和上隔入路)的围手术期和术后结果,并评估手术过程中和术后的差异:纳入标准为2010年1月至2020年12月期间接受二尖瓣手术的患者,分为3组:第1组(传统直接法,115人)、第2组(经隔法,33人)和第3组(上隔法,59人)。为扩大样本量,研究纳入了独立或与其他手术(如冠状动脉旁路移植术、主动脉瓣手术或迷宫术)同时进行的二尖瓣手术患者:结果:除第3组心内膜炎发生率较高外(P = .01),各组二尖瓣病因无明显差异。第 1 组患者接受择期手术和单独二尖瓣手术的频率更高(P = .008),主动脉夹闭和心肺旁路手术的持续时间也更短(P = .002)。相反,第 3 组患者的急诊手术比例更高(P = .01),重症监护室和住院时间更长(P = .001)。在永久起搏器植入、术后并发症或死亡率方面,各组之间没有发现明显差异:结论:采用这三种贲门切开术进行二尖瓣手术的安全性很高。传统的直接方法显著缩短了主动脉夹闭和心肺旁路手术的时间。上部室间隔方法主要用于急性病变,术后心律失常或永久性起搏器植入术没有明显增加,尽管这些患者在重症监护室和医院的住院时间较长。这些结果可能与潜在病理和手术干预的性质有关,而不是切口方法本身。
{"title":"Comparison of Perioperative and Postoperative Outcomes Among 3 Left Atrial Incisions: Conventional Direct, Transseptal, and Superior Septal Left Atriotomy.","authors":"Estelle Démoulin, Dionysios Adamopoulos, Tornike Sologashvili, Mathieu van Steenberghe, Jalal Jolou, Haran Burri, Christoph Huber, Mustafa Cikirikcioglu","doi":"10.14503/THIJ-23-8162","DOIUrl":"10.14503/THIJ-23-8162","url":null,"abstract":"<p><strong>Background: </strong>Achieving optimal exposure of the mitral valve during surgical intervention poses a significant challenge. This study aimed to compare perioperative and postoperative outcomes associated with 3 left atriotomy techniques in mitral valve surgery-the conventional direct, transseptal, and superior septal approaches-and assess differences during the surgical procedure and the postoperative period.</p><p><strong>Methods: </strong>Inclusion criteria were patients undergoing mitral valve surgery from January 2010 to December 2020, categorized into 3 cohorts: group 1 (conventional direct; n = 115), group 2 (transseptal; n = 33), and group 3 (superior septal; n = 59). To bolster sample size, the study included patients undergoing mitral valve surgery independently or in conjunction with other procedures (eg, coronary artery bypass grafting, aortictricuspid surgery, or maze procedure).</p><p><strong>Results: </strong>No substantial variance was observed in the etiology of mitral valve disease across groups, except for a higher incidence of endocarditis in group 3 (P = .01). Group 1 exhibited a higher frequency of elective surgeries and isolated mitral valve procedures (P = .008), along with reduced aortic clamping and cardiopulmonary bypass durations (P = .002). Conversely, group 3 patients represented a greater proportion of emergency procedures (P = .01) and prolonged intensive care unit and hospital stays (P = .001). No significant disparities were detected in terms of permanent pacemaker implantation, postoperative complications, or mortality among the groups.</p><p><strong>Conclusion: </strong>Mitral valve operations that employed these 3 atriotomy techniques demonstrated a safe profile. The conventional direct approach notably reduced aortic clamping and cardiopulmonary bypass durations. The superior septal method was primarily employed for acute pathologies, with no significant escalation in postoperative arrhythmias or permanent pacemaker implantation, although these patients had prolonged intensive care unit and hospital stays. These outcomes may be linked to the underlying pathology and nature of the surgical intervention rather than the incision method itself.</p>","PeriodicalId":48680,"journal":{"name":"Texas Heart Institute Journal","volume":"51 1","pages":""},"PeriodicalIF":0.9,"publicationDate":"2024-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11075488/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139643191","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgical Outcome of Postinfarction Left Ventricular Free Wall Rupture. 梗死后左心室游离壁破裂的手术结果
IF 0.9 4区 医学 Pub Date : 2024-01-31 DOI: 10.14503/THIJ-23-8213
Chan-Young Na

Background: Left ventricular free wall rupture (LVFWR) is a rare and fatal complication after acute myocardial infarction. Early recognition and aggressive treatment are recommended.

Methods: Between August 1999 and February 2023, 11 patients aged between 64 and 79 years developed LVFWR after acute myocardial infarction (mean interval, 3.5 days). Three patients had active bleeding (blowout-type LVFWR), and the other 8 patients experienced the oozing or sealed state. Eight patients were treated using a sutureless technique with Teflon felt and glue, 2 patients were treated using the primary suture closure technique, and 1 was treated using both the primary suture and the sutureless technique with Teflon felt and glue.

Results: One patient died in the operating room as a result of bleeding. Cardiovascular stability and hemostasis were achieved in the other 10 patients. There were 3 early deaths (all 3 cases as a result of area bleeding; 1 was treated with primary suture, 2 with sutureless glue). Three patients received percutaneous coronary intervention before discharge. All 8 remaining patients survived and were discharged. Three patients were lost to follow-up. The follow-up period ranged from 2 to 97 months, with 4 patients exhibiting New York Heart Association class I symptoms and 1 exhibiting New York Heart Association class II symptoms.

Conclusion: Optimal surgical treatment for postinfarction LVFWR remains controversial. The sutureless technique may be a promising strategy for treating postinfarction LVFWR.

背景:左心室游离壁破裂(LVFWR)是急性心肌梗死后一种罕见的致命并发症。建议及早识别并积极治疗:方法:1999 年 8 月至 2023 年 2 月期间,11 名年龄在 64 岁至 79 岁之间的患者在急性心肌梗死后发生了左心室游离壁破裂(平均间隔时间为 3.5 天)。其中 3 名患者为活动性出血(井喷型左心室纤维性血流),另外 8 名患者为渗出或密封状态。8 名患者使用特氟龙毡和胶水无缝合技术进行治疗,2 名患者使用主要缝合技术进行治疗,1 名患者同时使用主要缝合技术和特氟龙毡和胶水无缝合技术进行治疗:结果:一名患者因出血而死于手术室。结果:一名患者因出血而死于手术室,其他 10 名患者均达到了心血管稳定和止血效果。3例患者早期死亡(3例均为局部出血;1例采用初次缝合,2例采用无缝合胶水)。3 名患者在出院前接受了经皮冠状动脉介入治疗。其余 8 名患者全部存活并出院。3 名患者失去了随访机会。随访时间从2个月到97个月不等,其中4名患者表现出纽约心脏病协会I级症状,1名患者表现出纽约心脏病协会II级症状:结论:心梗后左心室纤维性纤维化的最佳手术治疗方法仍存在争议。无缝合技术可能是治疗心梗后左心室纤维性缺血的一种有前途的策略。
{"title":"Surgical Outcome of Postinfarction Left Ventricular Free Wall Rupture.","authors":"Chan-Young Na","doi":"10.14503/THIJ-23-8213","DOIUrl":"10.14503/THIJ-23-8213","url":null,"abstract":"<p><strong>Background: </strong>Left ventricular free wall rupture (LVFWR) is a rare and fatal complication after acute myocardial infarction. Early recognition and aggressive treatment are recommended.</p><p><strong>Methods: </strong>Between August 1999 and February 2023, 11 patients aged between 64 and 79 years developed LVFWR after acute myocardial infarction (mean interval, 3.5 days). Three patients had active bleeding (blowout-type LVFWR), and the other 8 patients experienced the oozing or sealed state. Eight patients were treated using a sutureless technique with Teflon felt and glue, 2 patients were treated using the primary suture closure technique, and 1 was treated using both the primary suture and the sutureless technique with Teflon felt and glue.</p><p><strong>Results: </strong>One patient died in the operating room as a result of bleeding. Cardiovascular stability and hemostasis were achieved in the other 10 patients. There were 3 early deaths (all 3 cases as a result of area bleeding; 1 was treated with primary suture, 2 with sutureless glue). Three patients received percutaneous coronary intervention before discharge. All 8 remaining patients survived and were discharged. Three patients were lost to follow-up. The follow-up period ranged from 2 to 97 months, with 4 patients exhibiting New York Heart Association class I symptoms and 1 exhibiting New York Heart Association class II symptoms.</p><p><strong>Conclusion: </strong>Optimal surgical treatment for postinfarction LVFWR remains controversial. The sutureless technique may be a promising strategy for treating postinfarction LVFWR.</p>","PeriodicalId":48680,"journal":{"name":"Texas Heart Institute Journal","volume":"51 1","pages":""},"PeriodicalIF":0.9,"publicationDate":"2024-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11075482/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139643192","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiometabolic Health: Actionable Prevention Strategies and New Care Models. 心脏代谢健康:可行的预防策略和新的护理模式。
IF 0.9 4区 医学 Pub Date : 2024-01-30 DOI: 10.14503/THIJ-23-8275
Omar Leonards, David Aguilar
{"title":"Cardiometabolic Health: Actionable Prevention Strategies and New Care Models.","authors":"Omar Leonards, David Aguilar","doi":"10.14503/THIJ-23-8275","DOIUrl":"10.14503/THIJ-23-8275","url":null,"abstract":"","PeriodicalId":48680,"journal":{"name":"Texas Heart Institute Journal","volume":"51 1","pages":""},"PeriodicalIF":0.9,"publicationDate":"2024-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11075626/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139576683","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Discordant Low-Gradient Aortic Stenosis: Assessing the Valve and the Myocardium. 不和谐的低梯度主动脉瓣狭窄:评估瓣膜和心肌
IF 0.9 4区 医学 Pub Date : 2024-01-01 DOI: 10.14503/THIJ-23-8288
Philippe Pibarot
{"title":"Discordant Low-Gradient Aortic Stenosis: Assessing the Valve and the Myocardium.","authors":"Philippe Pibarot","doi":"10.14503/THIJ-23-8288","DOIUrl":"10.14503/THIJ-23-8288","url":null,"abstract":"","PeriodicalId":48680,"journal":{"name":"Texas Heart Institute Journal","volume":"51 1","pages":""},"PeriodicalIF":0.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11075504/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139467180","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rethinking the Management of Asymptomatic Severe Aortic Valve Stenosis: Embracing Early Intervention for Better Outcomes. 重新思考无症状重度主动脉瓣狭窄的管理:拥抱早期干预,获得更好的疗效。
IF 0.9 4区 医学 Pub Date : 2024-01-01 DOI: 10.14503/THIJ-23-8295
Amjed Zidan, Renuka Jain
{"title":"Rethinking the Management of Asymptomatic Severe Aortic Valve Stenosis: Embracing Early Intervention for Better Outcomes.","authors":"Amjed Zidan, Renuka Jain","doi":"10.14503/THIJ-23-8295","DOIUrl":"10.14503/THIJ-23-8295","url":null,"abstract":"","PeriodicalId":48680,"journal":{"name":"Texas Heart Institute Journal","volume":"51 1","pages":""},"PeriodicalIF":0.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11075491/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139425793","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Paolo Angelini's Legacy in the Study of and Treatment for Anomalous Coronary Arteries. 保罗-安杰利尼在研究和治疗冠状动脉异常方面的遗产。
IF 0.9 4区 医学 Pub Date : 2023-12-19 DOI: 10.14503/THIJ-23-8351
Pitt O Lim
{"title":"Paolo Angelini's Legacy in the Study of and Treatment for Anomalous Coronary Arteries.","authors":"Pitt O Lim","doi":"10.14503/THIJ-23-8351","DOIUrl":"10.14503/THIJ-23-8351","url":null,"abstract":"","PeriodicalId":48680,"journal":{"name":"Texas Heart Institute Journal","volume":"50 6","pages":""},"PeriodicalIF":0.9,"publicationDate":"2023-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10751472/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138832490","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Characterization of Myocardial Injury With High-Sensitivity Troponin. 利用高敏肌钙蛋白确定心肌损伤的特征
IF 0.9 4区 医学 Pub Date : 2023-12-18 DOI: 10.14503/THIJ-23-8108
Sant Kumar, Nayrana Griffith, Dylan Walter, Michael Swett, Venkatesh Raman, Jose D Vargas, Brototo Deb, Jiling Chou, Ayah Arafat, Monvadi B Srichai

Background: High-sensitivity troponin I, cardiac form (hs-cTnI) accelerates the assessment of acute coronary syndrome. Little has been documented about its performance, how it relates to different types of myocardial injury, and its impact on morbidity and mortality. This study sought to expand understanding of hs-cTnI by characterizing types of myocardial injury, the impact of comorbidities, and 30-day outcomes.

Methods: The study retrospectively evaluated 1,975 patients with hs-cTnI levels obtained in the emergency department or inpatient setting from June to September 2020. Troponin was considered elevated if it was higher than the 99th percentile for either sex. Charts were reviewed to determine the presence of myocardial injury. Troponin elevation was adjusted for demographics, comorbidities, and kidney dysfunction. Thirty-day mortality and readmission rates were calculated.

Results: Of 1,975 patients, 468 (24%) had elevated hs-cTnI, and 330 (17%) had at least 1 type of myocardial injury, type 2 myocardial infarction being the most frequent. Sensitivity and specificity using the 99th percentile as a cutoff were 99% and 92%, respectively. The average maximum hs-cTnI level was significantly higher for type 1 myocardial infarction (P < .001). Being male, Black, non-Hispanic, and a hospital inpatient were all associated with higher initial and peak hs-cTnI levels (P < .001). Elevated hs-cTnI level, age, heart disease, kidney dysfunction, and inpatient status were predictive of 30-day mortality on multivariate analysis.

Conclusion: Elevated hs-cTnI levels in emergency department and inpatient settings occurs most commonly because of type 2 myocardial infarction. Maximum hs-cTnI level is associated with the patient's particular type of myocardial injury, certain demographics, and cardiovascular comorbidities, and it may be a predictor of 30-day outcomes.

背景:心肌型高敏肌钙蛋白 I(hs-cTnI)可加快对急性冠状动脉综合征的评估。关于它的性能、它与不同类型心肌损伤的关系以及它对发病率和死亡率的影响,鲜有文献记载。本研究试图通过描述心肌损伤类型、合并症的影响以及 30 天的结果来扩大对 hs-cTnI 的了解:该研究对 2020 年 6 月至 9 月期间在急诊科或住院环境中获得 hs-cTnI 水平的 1,975 名患者进行了回顾性评估。如果肌钙蛋白高于任一性别的第 99 百分位数,则认为肌钙蛋白升高。检查病历以确定是否存在心肌损伤。根据人口统计学、合并症和肾功能障碍对肌钙蛋白升高进行了调整。计算了三十天死亡率和再入院率:在 1,975 名患者中,468 人(24%)hs-cTnI 升高,330 人(17%)至少有一种心肌损伤,其中 2 型心肌梗死最为常见。以第 99 百分位数为临界值的敏感性和特异性分别为 99% 和 92%。1 型心肌梗死的 hs-cTnI 平均最高水平明显更高(P < .001)。男性、黑人、非西班牙裔和住院病人都与较高的初始和峰值 hs-cTnI 水平有关(P < .001)。在多变量分析中,hs-cTnI水平升高、年龄、心脏病、肾功能障碍和住院病人身份都是30天死亡率的预测因素:结论:急诊科和住院病人的 hs-cTnI 水平升高最常见于 2 型心肌梗死。hs-cTnI 的最高水平与患者心肌损伤的特定类型、某些人口统计学特征和心血管合并症有关,它可能是 30 天预后的预测因子。
{"title":"Characterization of Myocardial Injury With High-Sensitivity Troponin.","authors":"Sant Kumar, Nayrana Griffith, Dylan Walter, Michael Swett, Venkatesh Raman, Jose D Vargas, Brototo Deb, Jiling Chou, Ayah Arafat, Monvadi B Srichai","doi":"10.14503/THIJ-23-8108","DOIUrl":"10.14503/THIJ-23-8108","url":null,"abstract":"<p><strong>Background: </strong>High-sensitivity troponin I, cardiac form (hs-cTnI) accelerates the assessment of acute coronary syndrome. Little has been documented about its performance, how it relates to different types of myocardial injury, and its impact on morbidity and mortality. This study sought to expand understanding of hs-cTnI by characterizing types of myocardial injury, the impact of comorbidities, and 30-day outcomes.</p><p><strong>Methods: </strong>The study retrospectively evaluated 1,975 patients with hs-cTnI levels obtained in the emergency department or inpatient setting from June to September 2020. Troponin was considered elevated if it was higher than the 99th percentile for either sex. Charts were reviewed to determine the presence of myocardial injury. Troponin elevation was adjusted for demographics, comorbidities, and kidney dysfunction. Thirty-day mortality and readmission rates were calculated.</p><p><strong>Results: </strong>Of 1,975 patients, 468 (24%) had elevated hs-cTnI, and 330 (17%) had at least 1 type of myocardial injury, type 2 myocardial infarction being the most frequent. Sensitivity and specificity using the 99th percentile as a cutoff were 99% and 92%, respectively. The average maximum hs-cTnI level was significantly higher for type 1 myocardial infarction (P < .001). Being male, Black, non-Hispanic, and a hospital inpatient were all associated with higher initial and peak hs-cTnI levels (P < .001). Elevated hs-cTnI level, age, heart disease, kidney dysfunction, and inpatient status were predictive of 30-day mortality on multivariate analysis.</p><p><strong>Conclusion: </strong>Elevated hs-cTnI levels in emergency department and inpatient settings occurs most commonly because of type 2 myocardial infarction. Maximum hs-cTnI level is associated with the patient's particular type of myocardial injury, certain demographics, and cardiovascular comorbidities, and it may be a predictor of 30-day outcomes.</p>","PeriodicalId":48680,"journal":{"name":"Texas Heart Institute Journal","volume":"50 6","pages":""},"PeriodicalIF":0.9,"publicationDate":"2023-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10751476/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138812892","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Idiopathic Dilatation of the Right Atrium: Diagnosis and Management. 特发性右心房扩张:诊断与处理。
IF 0.9 4区 医学 Pub Date : 2023-12-13 DOI: 10.14503/THIJ-23-8192
Ljiljana Rankovic-Nicic, Milica Dragicevic-Antonic, Goran Loncar, Masa Petrovic, Zelimir Antonic, Milovan Bojic

Idiopathic dilatation of the right atrium is a rare condition with an unknown etiology. It is characterized by a significant enlargement of the right atrium without the presence of other valvopathies, intracardiac shunts, or pulmonary hypertension. This report presents the case of a 50-year-old woman with a significantly enlarged right atrium that was identified at birth; however, a definitive diagnosis was made later in life. The patient did not have any genetic diseases. Through the help of regular follow-up, anticoagulant therapy, previous radio-frequency ablation, and antiarrhythmic medications, she was able to carry a pregnancy to full term and live a regular life.

特发性右心房扩张是一种病因不明的罕见疾病。其特征是右心房明显增大,但不伴有其他瓣膜病、心内分流或肺动脉高压。本报告介绍了一名 50 岁女性的病例,她在出生时就发现右心房明显增大,但后来才确诊。患者没有任何遗传疾病。通过定期随访、抗凝治疗、先前的射频消融术和抗心律失常药物的帮助,她得以顺利怀孕并过上正常的生活。
{"title":"Idiopathic Dilatation of the Right Atrium: Diagnosis and Management.","authors":"Ljiljana Rankovic-Nicic, Milica Dragicevic-Antonic, Goran Loncar, Masa Petrovic, Zelimir Antonic, Milovan Bojic","doi":"10.14503/THIJ-23-8192","DOIUrl":"10.14503/THIJ-23-8192","url":null,"abstract":"<p><p>Idiopathic dilatation of the right atrium is a rare condition with an unknown etiology. It is characterized by a significant enlargement of the right atrium without the presence of other valvopathies, intracardiac shunts, or pulmonary hypertension. This report presents the case of a 50-year-old woman with a significantly enlarged right atrium that was identified at birth; however, a definitive diagnosis was made later in life. The patient did not have any genetic diseases. Through the help of regular follow-up, anticoagulant therapy, previous radio-frequency ablation, and antiarrhythmic medications, she was able to carry a pregnancy to full term and live a regular life.</p>","PeriodicalId":48680,"journal":{"name":"Texas Heart Institute Journal","volume":"50 6","pages":""},"PeriodicalIF":0.9,"publicationDate":"2023-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10751474/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138812894","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Transesophageal Cardiovascular Intervention. 经食道心血管介入治疗。
IF 0.9 4区 医学 Pub Date : 2023-12-07 DOI: 10.14503/THIJ-23-8230
Alexander Loch, Victoria Wen Yeng Teoh, Ida Normiha Hilmi

Endoscopic ultrasonography-guided transesophageal pericardiocentesis was performed for a posteriorly located effusion not amenable to transthoracic drainage in a 58-year-old woman with a history of recurrent breast adenocarcinoma who presented with dyspnea. The patient had a pericardial effusion that resulted in cardiac tamponade. Transthoracic pericardiocentesis was unsuitable because of the posterior location of the effusion. Pericardiocentesis via the transesophageal route was performed. The pericardial sac was punctured with a 19-gauge needle, and 245 mL of pericardial fluid were aspirated, resulting in the resolution of the tamponade physiology. Endoscopic ultrasonography-guided transesophageal drainage is a novel and promising therapeutic option for posteriorly located pericardial effusions.

一名 58 岁的女性患者因呼吸困难出现经胸引流不畅的后方积液,在内窥镜超声波引导下进行了经食道心包穿刺术,患者曾患复发性乳腺腺癌。患者心包积液导致心脏填塞。由于渗出物位于后方,经胸心包穿刺术并不合适。于是通过经食道途径进行了心包穿刺。用 19 号针头穿刺心包囊,抽吸出 245 毫升心包积液,从而消除了心包填塞的生理现象。内镜超声引导下的经食道引流术是治疗后位心包积液的一种新颖而有前景的方法。
{"title":"A Transesophageal Cardiovascular Intervention.","authors":"Alexander Loch, Victoria Wen Yeng Teoh, Ida Normiha Hilmi","doi":"10.14503/THIJ-23-8230","DOIUrl":"10.14503/THIJ-23-8230","url":null,"abstract":"<p><p>Endoscopic ultrasonography-guided transesophageal pericardiocentesis was performed for a posteriorly located effusion not amenable to transthoracic drainage in a 58-year-old woman with a history of recurrent breast adenocarcinoma who presented with dyspnea. The patient had a pericardial effusion that resulted in cardiac tamponade. Transthoracic pericardiocentesis was unsuitable because of the posterior location of the effusion. Pericardiocentesis via the transesophageal route was performed. The pericardial sac was punctured with a 19-gauge needle, and 245 mL of pericardial fluid were aspirated, resulting in the resolution of the tamponade physiology. Endoscopic ultrasonography-guided transesophageal drainage is a novel and promising therapeutic option for posteriorly located pericardial effusions.</p>","PeriodicalId":48680,"journal":{"name":"Texas Heart Institute Journal","volume":"50 6","pages":""},"PeriodicalIF":0.9,"publicationDate":"2023-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10751479/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138812890","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Texas Heart Institute Journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1